Goldman Sachs Group Inc Neurocrine Biosciences Inc Put Options Transaction History

Goldman Sachs Group Inc

  • $780 Billion
  • Q3 2025

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$123.98 - $146.67 $1.09 Million - $1.29 Million
-8,800 Reduced 77.88%
2,500 $350,000
Q2 2025

Aug 14, 2025
BUY
$87.54 - $128.18 $989,202 - $1.45 Million
11,300 New
11,300 $1.42 Million
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $2.39 Million - $3.19 Million
30,000 New
30,000 $2.56 Million

Others Institutions Holding NBIX

# of Institutions
724
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email